This content is in French.
Ribociclib in early breast cancer
29 mars 2024
If ribociclib has a positive effect on overall survival in patients with HR+ HER2- advanced breast cancer, what about early breast cancer? In this international, randomized, open-label Phase 3 trial, patients were randomly…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Dennis Slamon et al. Ribociclib plus Endocrine Therapy in Early Breast Cancer. N Engl J Med. 2024 Mar 21;390(12):1080-1091
View the source
